UBS/PUT/PFIZER INC/30.5/0.1/20.09.24 Share Price

Warrant

CH1280725578

Market Closed - Deutsche Boerse AG 17:23:48 03/07/2024 BST
0.28 EUR +3.70% Intraday chart for UBS/PUT/PFIZER INC/30.5/0.1/20.09.24
Current month+7.69%
1 month+31.46%
Date Price Change
03/07/24 0.28 +3.70%
02/07/24 0.27 +9.76%
01/07/24 0.246 -5.38%
28/06/24 0.26 -10.34%
27/06/24 0.29 -6.45%

Delayed Quote Deutsche Boerse AG

Last update July 03, 2024 at 05:23 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying PFIZER, INC.
Issuer UBS
WKN UL4GFK
ISINCH1280725578
Date issued 11/07/2023
Strike 30.5 $
Maturity 20/09/2024 (79 Days)
Parity 10 : 1
Emission price 0.16
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.54
Lowest since issue 0.094
Delta-0.74x
Omega 6.240
Premium2.07x
Gearing8.44x
Moneyness 1.098
Difference Strike 2.8 $
Difference Strike %+9.18%
Spread 0.05
Spread %15.15%
Intrinsic value 0.2596

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.7 USD
Average target price
31.92 USD
Spread / Average Target
+15.22%
Consensus